A multi-faceted treatment program for young adults addicted to opioid drugs was unveiled today at the National Institute on Drug Abuse's (NIDA) Blending Conference in Albuquerque, N.M. This eighth meeting in the series brings together researchers and clinicians so their latest findings can be immediately applied to the needs of patients and their families dealing with addictive disorders. NIDA is a component of the National Institutes of Health (see also Biological Products).
The new treatment product, Buprenorphine Treatment for Young Adults, was based on research by NIDA's Clinical Trials Network in partnership with the Substance Abuse and Mental Health Services …
No comments:
Post a Comment